| Q45907681 | Antimalarial interaction of quinine and quinidine with clarithromycin. |
| Q36646467 | Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells |
| Q47985538 | Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice |
| Q49140346 | Direct and quantitative evaluation of the human CYP3A4 contribution (fm) to drug clearance using the in vitro SILENSOMES model |
| Q45061484 | Identification and relative contributions of human cytochrome P450 isoforms involved in the metabolism of glibenclamide and lansoprazole: evaluation of an approach based on the in vitro substrate disappearance rate |
| Q58555455 | In Vitro Assessment of Potential for CYP-Inhibition-Based Drug-Drug Interaction Between Vonoprazan and Clopidogrel |
| Q37247655 | Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration |
| Q33613354 | Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin |
| Q46726525 | Usefulness of hepatocytes for evaluating the genetic polymorphism of CYP2D6 substrates |